These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10512133)

  • 1. Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
    Shevlin PM; Muers MF; Peake MD; Hosker HS; Stead ML; Poulter KM; Brown JM
    Lung Cancer; 1999 Sep; 25(3):215-6. PubMed ID: 10512133
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the treatment of small cell lung cancer].
    Ruffie P
    Pathol Biol (Paris); 1992 Nov; 39(9):940-1. PubMed ID: 1311448
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
    Thatcher N; Qian W; Clark PI; Hopwood P; Sambrook RJ; Owens R; Stephens RJ; Girling DJ
    J Clin Oncol; 2005 Nov; 23(33):8371-9. PubMed ID: 16293867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined platinum etoposide with radiation therapy in limited stage small cell lung cancer: an effective treatment strategy.
    Turrisi AT
    Lung Cancer; 1995 Jun; 12 Suppl 3():S41-51. PubMed ID: 7551955
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group.
    Nakanishi Y; Kawarada Y; Hirose N; Ninomiya K; Miyazaki M; Miyazaki N; Kurita Y; Kanegae H; Ohgushi O; Ogata K; Yamazaki H; Inutsuka S; Hara N
    Cancer Chemother Pharmacol; 1998; 41(6):453-6. PubMed ID: 9554588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
    Hastürk S; Kurt B; Kocabas A; Orüç O; Burgut R
    J Chemother; 1997 Feb; 9(1):66-71. PubMed ID: 9106021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
    Mascaux C; Paesmans M; Berghmans T; Branle F; Lafitte JJ; Lemaitre F; Meert AP; Vermylen P; Sculier JP;
    Lung Cancer; 2000 Oct; 30(1):23-36. PubMed ID: 11008007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer.
    Carney DN
    Lung Cancer; 1995 Jun; 12 Suppl 3():S77-83. PubMed ID: 7551960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
    Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
    J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation].
    Fietkau R; Sauer R
    Strahlenther Onkol; 2002 Nov; 178(11):585-8. PubMed ID: 12518770
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
    Dowlati A; Crosby L; Remick SC; Makkar V; Levitan N
    Lung Cancer; 2001 May; 32(2):155-62. PubMed ID: 11325486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of the possibility of long-term survival of patients with small cell lung cancer].
    Pawlicki M; Krochmal M; Krzemieniecki K
    Pneumonol Alergol Pol; 1992; 60(5-6):26-9. PubMed ID: 1337851
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
    Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F
    Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer.
    Shevlin PM; Muers MF; Peake MD; Hosker HS; Stead ML; Poulter KM; Brown JM
    Lung Cancer; 1998 Aug; 21(2):115-26. PubMed ID: 9829545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.